New Phase I trial data finds that people who responded to ELI-002 survived longer and stayed cancer-free longer than usual.

Communication Technology Services (CTS), an in-building and campus connectivity solution provider, has announced the ...

New York City-based Memorial Sloan Kettering Cancer Center has unified its Epic EHR so its patients, providers, researchers and labs are all on the same system. Here are six things to know from an Aug ...

Bayer announces deal with Kumquat for a pancreatic cancer KRAS inhibitor, plus, promising mRNA vaccine research emerges from ...

Rectal cancer chemoradiotherapy is tied to an increased risk for second nonpelvic cancers but not second pelvic cancers.

A New York City cancer center just received two sizable grants to fund research into pediatric cancer. Memorial Sloan ...

“Dupilumab appears promising as a steroid-sparing treatment of ADC-induced cutaneous toxicities,” which “are difficult to ...

The American Cancer Society (ACS) has awarded The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai a $4.08 million grant to establish the Cancer Health Research Center at Mount ...

Dr. Jonathan Rosenberg, chief attending physician at Memorial Sloan Kettering Cancer Center, discusses coach Deion Sanders’ battle with bladder cancer.

Researchers typically ask why people get cancer. What if they studied why some survive — or never develop the disease?

Doctors at the National Institutes of Health have discovered a new cause of skin cancer, according to a report in the New ...

Music therapy is emerging as a powerful, evidence-based tool in cancer survivorship care. A recent MSK study finds it as ...